Engineered T cell manufacturing service – Accelerate your CGT journey with precision and speed

Our manufacturing workflows for T cell engineering are built on the industry-leading CliniMACS Prodigy® Platform. Integrated and automated, these processes are clinically and commercially proven, delivering robust performance in scalability, consistency, and time-to-market. Leverage our expertise to confidently achieve your cell therapy manufacturing goals.

Expertise you can trust

8 years of experience in T cell engineering and continuously pushing the boundaries

Viral and non-viral
engineering expertise*

^{*Viral: Lentiviral vector, gamma retroviral vector, adenovirus, AAV;}
^{non-viral: CRISPR RNP, ZFN, plasmid DNA, mRNA, transposon/transposase}

3 late-stage clinical programs

Leverage the leading platform for T cell engineering

Clinical and commercialization experience with autologous and allogeneic programs
As standard or as custom as you need it
Proven platforms to automate your manufacturing and analytics early in your program

Illustration showing the comparison of transducing titers between client plasmids vs. Miltenyi-optimized designs

The CliniMACS Prodigy T Cell Transduction (TCT) Process achieves consistent transduction rates across different runs and constructs.

Excellent transduction efficiency and CAR/TCR frequency

Our automated CliniMACS Prodigy T Cell Transduction Process has been validated in industry and numerous clinical studies. It is designed for standardized and reliable cell manufacturing, delivering excellent transduction efficiencies and target cell frequencies.

Download the brochure on our T cell manufacturing solutions.

Excellent CAR T cell expansion rates from fresh and frozen starting materials using the CliniMACS Prodigy Platform.

Optimized T cell expansion rates and final cell count

Our integrated, single platform process boosts your cell expansion rates and maintains favorable T cell phenotypes. Whether you choose fresh or frozen starting materials, different stimulation strategies, or varied production scales, our robust processes bring you closer to your goals.

What you can expect:

Consultative and collaborative approach
Robust, automated manufacturing process
From preclinical to GMP in as little as 9 months*
Data packages to enable your CMC section of regulatory filings
Flexible clinical manufacturing and scheduling

^{*Based on data collected through 2024. Miltenyi Biotec does not guarantee that any specific delivery date(s) will be met. Individual timelines may vary based on factors such as client’s stage of development and specifications.}

Interested in more information? Get the details!

Engineered T cell manufacturing service – Accelerate your CGT journey with precision and speed

Expertise you can trust

8 years of experience in T cell engineering and continuously pushing the boundaries

Viral and non-viral engineering expertise*

3 late-stage clinical programs

Leverage the leading platform for T cell engineering

Excellent transduction efficiency and CAR/TCR frequency

Optimized T cell expansion rates and final cell count

What you can expect:

Interested in more information? Get the details!

Webinar

Further information

Further information

Questions? Want to know more?Fill out our form to get in touch with our experts.

Viral and non-viral
engineering expertise*

Questions? Want to know more?
Fill out our form to get in touch with our experts.